华纳药厂全资子公司获硫酸沙丁胺醇上市批准

财中社11-19

财中社11月19日电华纳药厂（688799）发布自愿披露公告，宣布其全资子公司获得国家药品监督管理局批准的硫酸沙丁胺醇化学原料药上市申请通知书。该药品登记号为Y20230000262，批准注册后将可在国内制剂中使用。硫酸沙丁胺醇作为一种β2-肾上腺素受体激动剂，主要用于治疗支气管哮喘等呼吸道疾病。公告指出，获得批准将丰富公司产品线并提升核心竞争力。然而，目前该原料药尚未销售，生产和销售时间仍存在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484913281?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-19 17:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484913281","market":"sh","top_or_hot":-1,"title":"华纳药厂全资子公司获硫酸沙丁胺醇上市批准","media":"财中社","content":"<div>\n<p>财中社11月19日电华纳药厂（688799）发布自愿披露公告，宣布其全资子公司获得国家药品监督管理局批准的硫酸沙丁胺醇化学原料药上市申请通知书。该药品登记号为Y20230000262，批准注册后将可在国内制剂中使用。硫酸沙丁胺醇作为一种β2-肾上腺素受体激动剂，主要用于治疗支气管哮喘等呼吸道疾病。公告指出，获得批准将丰富公司产品线并提升核心竞争力。然而，目前该原料药尚未销售，生产和销售时间仍存在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119175938a2456117&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华纳药厂全资子公司获硫酸沙丁胺醇上市批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华纳药厂全资子公司获硫酸沙丁胺醇上市批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-19 17:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119175938a2456117&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社11月19日电华纳药厂（688799）发布自愿披露公告，宣布其全资子公司获得国家药品监督管理局批准的硫酸沙丁胺醇化学原料药上市申请通知书。该药品登记号为Y20230000262，批准注册后将可在国内制剂中使用。硫酸沙丁胺醇作为一种β2-肾上腺素受体激动剂，主要用于治疗支气管哮喘等呼吸道疾病。公告指出，获得批准将丰富公司产品线并提升核心竞争力。然而，目前该原料药尚未销售，生产和销售时间仍存在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119175938a2456117&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119175938a2456117&s=b","article_id":"2484913281","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119175938a2456117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484913281","pubTimestamp":1732009225,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"财中社11月19日电华纳药厂 发布自愿披露公告，宣布其全资子公司获得国家药品监督管理局批准的硫酸沙丁胺醇化学原料药上市申请通知书。硫酸沙丁胺醇作为一种β2-肾上腺素受体激动剂，主要用于治疗支气管哮喘等呼吸道疾病。公告指出，获得批准将丰富公司产品线并提升核心竞争力。2024年前三季度，华纳药厂实现收入10.69亿元，归母净利润1.58亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688799":"华纳药厂","BK0239":"医药制造"},"translate_title":"Warner Pharmaceuticals' wholly-owned subsidiary receives marketing approval for salbutamol sulfate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688799":1},"content_text":"财中社11月19日电华纳药厂（688799）发布自愿披露公告，宣布其全资子公司获得国家药品监督管理局批准的硫酸沙丁胺醇化学原料药上市申请通知书。该药品登记号为Y20230000262，批准注册后将可在国内制剂中使用。硫酸沙丁胺醇作为一种β2-肾上腺素受体激动剂，主要用于治疗支气管哮喘等呼吸道疾病。公告指出，获得批准将丰富公司产品线并提升核心竞争力。然而，目前该原料药尚未销售，生产和销售时间仍存在不确定性，受GMP符合性检查进度及市场环境变化等因素影响。公司提醒投资者需谨慎决策，防范投资风险。2024年前三季度，华纳药厂实现收入10.69亿元，归母净利润1.58亿元。文章来源：财中社原标题：华纳药厂全资子公司获硫酸沙丁胺醇上市批准","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484913281"}